Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol

Abstract Introduction- Now a day’s colorectal cancer (CRC) is one of the most deadly cancers in the world. The objective of this investigation was to evaluate the protective effect of gallic acid and pyrogallol in colorectal cancer. Previous reports suggest that there is an association present betwe...

Full description

Bibliographic Details
Main Authors: Debanjan Mitra, Anumita Dey, Ishita Biswas, Pradeep Das Mohapatra
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2021-03-01
Series:Iranian Journal of Colorectal Research
Subjects:
Online Access:https://colorectalresearch.sums.ac.ir/article_47450_224f0bde28b2fefd56816886d6dc4b96.pdf
_version_ 1811181725244456960
author Debanjan Mitra
Anumita Dey
Ishita Biswas
Pradeep Das Mohapatra
author_facet Debanjan Mitra
Anumita Dey
Ishita Biswas
Pradeep Das Mohapatra
author_sort Debanjan Mitra
collection DOAJ
description Abstract Introduction- Now a day’s colorectal cancer (CRC) is one of the most deadly cancers in the world. The objective of this investigation was to evaluate the protective effect of gallic acid and pyrogallol in colorectal cancer. Previous reports suggest that there is an association present between some tannase producing bacteria and colorectal cancer. Tannase hydrolyze tannic acid into gallic acid and pyrogallol. Are those compounds have any therapeutic effect on colorectal cancer? This study will help to find those quarries. Methods-The remedial effect of gallic acid and pyrogallol was studied by descriptor properties and molecular docking methods. 100 CRC causing protein structures were docked in this investigation. Results- Lipinski Rule of Five and other descriptor properties of those compounds have showed their nontoxic and therapeutic nature. Molecular docking studies have showed highest score -38.22 KJ/Mol with gallic acid and -33.6 KJ/Mol with pyrogallol. Conclusion- This is the first report on docking investigation of these large numbers of protein. The findings of this research concluded that gallic acid and pyrogallol have a protective effect in colorectal cancer by stopping the effect of those CRC causing protein.
first_indexed 2024-04-11T09:21:11Z
format Article
id doaj.art-27bc9541dfa84582b575c4957aa5f52e
institution Directory Open Access Journal
issn 2783-2430
language English
last_indexed 2024-04-11T09:21:11Z
publishDate 2021-03-01
publisher Shiraz University of Medical Sciences
record_format Article
series Iranian Journal of Colorectal Research
spelling doaj.art-27bc9541dfa84582b575c4957aa5f52e2022-12-22T04:32:10ZengShiraz University of Medical SciencesIranian Journal of Colorectal Research2783-24302021-03-0191323910.30476/acrr.2021.89642.108047450Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and PyrogallolDebanjan Mitra0Anumita Dey1Ishita Biswas2Pradeep Das Mohapatra3Department of Microbiology, Raiganj University, Raiganj, WB, IndiaDepartment of Microbiology, Raiganj University, Raiganj, WB, IndiaDepartment of Microbiology, Raiganj University, Raiganj, WB, IndiaDepartment of Microbiology, Raiganj University, Raiganj, WB, IndiaAbstract Introduction- Now a day’s colorectal cancer (CRC) is one of the most deadly cancers in the world. The objective of this investigation was to evaluate the protective effect of gallic acid and pyrogallol in colorectal cancer. Previous reports suggest that there is an association present between some tannase producing bacteria and colorectal cancer. Tannase hydrolyze tannic acid into gallic acid and pyrogallol. Are those compounds have any therapeutic effect on colorectal cancer? This study will help to find those quarries. Methods-The remedial effect of gallic acid and pyrogallol was studied by descriptor properties and molecular docking methods. 100 CRC causing protein structures were docked in this investigation. Results- Lipinski Rule of Five and other descriptor properties of those compounds have showed their nontoxic and therapeutic nature. Molecular docking studies have showed highest score -38.22 KJ/Mol with gallic acid and -33.6 KJ/Mol with pyrogallol. Conclusion- This is the first report on docking investigation of these large numbers of protein. The findings of this research concluded that gallic acid and pyrogallol have a protective effect in colorectal cancer by stopping the effect of those CRC causing protein.https://colorectalresearch.sums.ac.ir/article_47450_224f0bde28b2fefd56816886d6dc4b96.pdfcolorectal cancerdescriptor propertiesmolecular dockingbinding energy
spellingShingle Debanjan Mitra
Anumita Dey
Ishita Biswas
Pradeep Das Mohapatra
Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol
Iranian Journal of Colorectal Research
colorectal cancer
descriptor properties
molecular docking
binding energy
title Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol
title_full Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol
title_fullStr Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol
title_full_unstemmed Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol
title_short Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol
title_sort bioactive compounds as a potential inhibitor of colorectal cancer an insilico study of gallic acid and pyrogallol
topic colorectal cancer
descriptor properties
molecular docking
binding energy
url https://colorectalresearch.sums.ac.ir/article_47450_224f0bde28b2fefd56816886d6dc4b96.pdf
work_keys_str_mv AT debanjanmitra bioactivecompoundsasapotentialinhibitorofcolorectalcanceraninsilicostudyofgallicacidandpyrogallol
AT anumitadey bioactivecompoundsasapotentialinhibitorofcolorectalcanceraninsilicostudyofgallicacidandpyrogallol
AT ishitabiswas bioactivecompoundsasapotentialinhibitorofcolorectalcanceraninsilicostudyofgallicacidandpyrogallol
AT pradeepdasmohapatra bioactivecompoundsasapotentialinhibitorofcolorectalcanceraninsilicostudyofgallicacidandpyrogallol